Rectus Sheath Block in Cardiac Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Rectus sheath block.
- Who it may be relevant to
- Registry conditions: Cardiac Disease, Postoperative Pain. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.
Interventions
- Procedure Rectus sheath block
Participants will receive an ultrasound guided rectus sheath block with local anesthetic
Primary outcome measures
- Opioid consumption [Time frame: 72 hours postoperatively]
- VAS pain scores [Time frame: 72 hours postoperatively]
Secondary outcome measures (3)
- Length of stay in ICU [Time frame: 72 hours]
- Length of hospital stay [Time frame: 72 hours]
- Time to extubation [Time frame: 72 hours]
Eligibility criteria
Inclusion criteria
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Adults 18-85 years old
- Scheduled to undergo cardiac procedures involving chest tubes
- Male or female
Exclusion criteria
- An individual who meets any of the following criteria will be excluded from participation in this study:
- ASA class V
- Urgent or emergent surgery
- Contraindications to administration of local anesthesia (e.g. local anesthetic allergy)
- History of substance abuse or chronic opioid use
- Patient refusal or inability to consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Mount Sinai Morningside Hospital Center — New York
Identifiers
NCT: NCT05833048 · STUDY-23-00096